en · de · es · fr · pt
cjc-1295-notes.peptides9000.com › Topic › Albumin Binding And Duration Of Action — Research Overview

Albumin Binding And Duration Of Action — Research Overview

By Editorial Desk · published 2026-01-23 · last reviewed 2026-03-02 · Topic

A practical reference on Albumin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-03-02. Anything still debated is marked as such rather than presented as settled.

Albumin Binding and Duration of Action

The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.

Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.

Identity and Naming History

CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.

The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.

Cjc-1295 at a glance

PropertyValueNotes
Duration with linkerSeveral daysReported in early human work
Duration without linkerTens of minutesShort plasma residence
Albumin attachment siteCysteine-34Covalent maleimide reaction
Primary receptorPituitary GHRH receptorStimulates growth hormone release
Downstream markerInsulin-like growth factor 1Indirect measure of activity

Mechanism and Pharmacokinetics

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Related pages on this site

Background and Molecular Features

Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.

The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.

Notes from published material

=== Angevin transition === After the Polish royal line and Piast junior branch died out in 1370, Poland came under the rule of Louis I of Hungary of the Capetian House of Anjou, who presided over a union of Hungary and Poland that lasted until 1382. In 1374, Louis granted the Polish nobility the Privilege of Koszyce to assure the succession of one of his daughters in Poland. His youngest daughter Jadwiga (d. 1399) assumed the Polish throne in 1384.

) evaluated for three mountain-normal lines constructed from surface observations in and around the area affected by the cold air damming—the damming region. The "x" denotes either sea level pressure or potential temperature (θ) and the subscripts 1–3 denote stations running from west to east along the line, while the "d" represents the distance between two stations. Negative Laplacian values are typically associated with pressure maxima at the center station, while positive Laplacian values usually correspond to colder temperatures in the center of the section.

=== Human monoclonal antibodies === Human monoclonal antibodies (suffix -umab) are produced using transgenic mice or phage display libraries by transferring human immunoglobulin genes into the murine genome and vaccinating the transgenic mouse against the desired antigen, leading to the production of appropriate monoclonal antibodies. Murine antibodies in vitro are thereby transformed into fully human antibodies. The heavy and light chains of human IgG proteins are expressed in structural polymorphic (allotypic) forms. Human IgG allotype is one of the many factors that can contribute to immunogenicity.

Sources: en.wikipedia.org

Further detail

These apples, engineered by Okanagan Specialty Fruits Inc, are a result of applying gene splicing, a laboratory technique that has allowed for the reduction in polyphenol oxidase. Another type of issue that is closely studied is the browning of seafood. Seafood, in particular shrimp, is a staple consumed by people all over the world. The browning of shrimp, which is actually referred to as melanosis, creates a great concern for food handlers and consumers. Melanosis mainly occurs during postmortem handling and refrigerated storage. Recent studies have found a plant extract that acts as an anti-melatonin polyphenol oxidase inhibitor serves the same function as sulfites but without the health risks.

The pathway starts with glycerol 3-phosphate, which gets converted to lysophosphatidate via the addition of a fatty acid chain provided by acyl coenzyme A. Then, lysophosphatidate is converted to phosphatidate via the addition of another fatty acid chain contributed by a second acyl CoA; all of these steps are catalyzed by the glycerol phosphate acyltransferase enzyme. Phospholipid synthesis continues in the endoplasmic reticulum, and the biosynthesis pathway diverges depending on the components of the particular phospholipid.

However, these central Appalachian populations are scattered and very small. Another species of great interest is the beaver (Castor canadensis), which is showing a great resurgence in numbers after its near extirpation for its pelt. This resurgence is bringing about a drastic alteration in habitat through the construction of dams and other structures throughout the mountains. Other common forest animals are the black bear (Ursus americanus), striped skunk (Mephitis mephitis), raccoon (Procyon lotor), opossum (Didelphis virginianus), woodchuck (Marmota monax), bobcat (Lynx rufus), gray fox (Urocyon cinereoargenteus), red fox (Vulpes vulpes) and in recent years, the coyote (Canis latrans), another species favored by the advent of Europeans and the extirpation of eastern and red wolves (Canis rufus). European boars (Sus scrofa) were introduced in the early 20th century. Characteristic birds of the forest are wild turkey (Meleagris gallopavo silvestris), ruffed grouse (Bonasa umbellus), mourning dove (Zenaida macroura), common raven (Corvus corax), wood duck (Aix sponsa), great horned owl (Bubo virginianus), barred owl (Strix varia), screech owl (Megascops asio), red-tailed hawk (Buteo jamaicensis), red-shouldered hawk (Buteo lineatus), and northern goshawk, as well as a great variety of "songbirds" (Passeriformes), like the warblers in particular. Of great importance are the many species of salamanders and, in particular, the lungless species (family Plethodontidae) that live in great abundance concealed by leaves and debris, on the forest floor.

Sources: en.wikipedia.org

Frequently asked questions

How does the reactive group attach to albumin?

A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.

Does the modification change how the peptide signals?

The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.

Are human half-life figures well established?

Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.

Is this compound a naturally occurring hormone?

No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.

Network